Salem, Oregon, Practice Provides Much-Needed Services to Its Community

Hematology Oncology of Salem pic

Hematology Oncology of Salem

The winner of the Cambridge Who’s Who Professional of the Year in Medical Oncology and Hematology, triple board-certified physician Natasha Tiffany, MD, treats patients at Hematology Oncology of Salem, located in Oregon. Natasha Tiffany, MD, and the office’s other qualified staff members provide care for individuals with cancer and blood disorders. The practice has a focus on designing personalized treatment plans tailored to each patient’s needs.

Despite the demand for a state-of-the-art cancer treatment center in the Salem area, residents had few options before Hematology Oncology of Salem opened in 2000. The clinic now employs eight physicians, a family nurse practitioner, and two certified physician assistants. In 2002, the practice expanded to a second clinic in McMinnville, Oregon. It also has offices in Silverton and Woodburn, Oregon.

To learn more about Hematology Oncology of Salem, please visit Among other information, the website contains video testimonials from patients who with the help of the practice have beaten cancer and blood disorders.


Interview with Natasha Tiffany, MD (Part I)

Natasha Tiffany, MD, currently provides a range of cancer treatments to patients at Hematology Oncology of Salem in Salem, Oregon, where she has worked since 2004. We recently sat down with Dr. Tiffany to discuss her work and the types of cancer therapies she offers to patients.

Can you tell us a little bit about some of the research that you have conducted over the course of your career?
Natasha Tiffany, MD: Of course. For two years in the early 2000s, I worked with Dr. Tomasz Beer studying the effectiveness of two drugs, Zometa and Gleevec, on androgen-independent prostate cancer. With Dr. Beer, I have also published research on the effects of Docetaxel, Calcitriol, and Estramustine in androgen-independent prostate cancer. I have participated in the research of multiple myeloma, as well. My earlier research was in neurology, particularly looking at stroke and Parkinson’s disease.

You also have been involved in cancer research through other professional activities. Can you discuss some of those?
Natasha Tiffany, MD: At the Salem Cancer Institute, we are building our clinical trials program so we can offer cutting-edge treatments to patients that have not yet been FDA approved. I believe clinical research is vital to the future of cancer treatments, and it can offer important drugs that patients otherwise would not have been able to receive. We are hoping to have a clinical trial available for each of the major stages of most cancers so that we can offer these trials to those patients who are interested. I serve on the Board of Directors for Willamette Clinical Research and am a member of the Southwest Oncology Group, which designs and funds clinical trial.